- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03494062
Exercise in Juvenile Takayasu Disease
April 10, 2018 updated by: Bruno Gualano, University of Sao Paulo
Exercise in Juvenile Takayasu Disease: a Randomized Controlled Trial
Juvenile Takayasu disease is characterized by chronic inflammation that leads to vascular disease.
Exercise may render anti-inflammatory effects and protect against cardiovascular events.
This trial aims to investigate the therapeutic role of exercise in juvenile Takayasu disease.
Study Overview
Detailed Description
Takayasu's Arteritis (TA) is a chronic inflammatory disease that affects large and medium-sized arteries.
The number of cases describe in children and adolescents has growing, and the hypertension is one of the symptoms most common, followed by other manifestations that affects cardiovascular systems.
All clinical manifestations may aggravate by physical inactivity and can creating a vicious cycle of inflammation, whereas the risks of morbidity and mortality increase significantly in the pediatric population, impairing function and physical capacity, quality of life and evolution to adult life.
Thereby, physical exercise it is show to be an efficient strategy to reduce all these risk factors, however, no one study, until now, was conducted to available the effects of exercise in children with TA.
Objective: Investigated the effects of 12-week home-based exercise program, where the patients receive a guideline from a physical education professional, teaching how to do the exercise at home.
The beneficial effects of the programs expect is to be associated with improved cardiovascular risk factors, function and physical capacity, and body composition.
Methods: This is a prospective, longitudinal and randomized clinical trial.
All patients will be recruited at the Clinical Hospital of the University of Sao Paulo Medical School (HC-FMUSP), in the Laboratory of Evaluation and Conditioning in Rheumatology, Pediatric Rheumatology outpatient clinics of the Department of Pediatrics, Federal University of São Paulo and The Children's Institute of the University of São Paulo and the Vasculitis Unit of the HC-FMUSP Rheumatology Service.
In order to evaluate the therapeutic effects of exercise program act on TA, the following pre and post intervention evaluations will be performed: physical activity level; Global clinical evaluation; Anthropometry and body composition; Hematological and inflammatory blood parameters; Cardiovascular risk factors; Aerobic capacity; Functional capacity and fatigue; quality of life; and 18 FDG PET with magnetic resonance angiography.
Study Type
Interventional
Enrollment (Anticipated)
21
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Camilla CA Astley, Masters
- Phone Number: 5511964721104
- Email: camilla.astley@gmail.com
Study Locations
-
-
Castanho
-
São Paulo, Castanho, Brazil, 05303-000
- Recruiting
- University of Sao Paulo
-
Contact:
- Camilla Astley
- Phone Number: 551126618022
- Email: camilla.astley@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
7 years to 25 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- diagnosis of juvenile Takayasu disease
Exclusion Criteria:
- cardiac and renal insufficiency
- physical limitation hampering exercise training
- non-controlled metabolic disorders
- associated chronic diseases (last 6 months)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control
Usual care
|
|
Experimental: Exercise
Home-based exercise intervention
|
Home-based exercise training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Arterial inflammation
Time Frame: 12 weeks
|
as assessed by positron emission tomography - magnetic ressonance (PET-MR)
|
12 weeks
|
Blood inflammatory markers
Time Frame: 12 weeks
|
interleukin-6, interleukin 10, interleukin-12
|
12 weeks
|
Blood inflammatory marker
Time Frame: 12 weeks
|
C-reactive protein
|
12 weeks
|
velocity sedimentation rate
Time Frame: 12 weeks
|
velocity sedimentation rate
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maximal aerobic capacity
Time Frame: 12 weeks
|
as assessed by maximal cardiopulmonary test
|
12 weeks
|
Body composition
Time Frame: 12 weeks
|
Lean, fat and bone mass, as assessed by dual energy x-ray absorptiometry
|
12 weeks
|
Timed stands test
Time Frame: 12 weeks
|
The test is performed by measuring the time to stand up and down for 30 seconds.
The patient should make two attempts and the best performance will be considered for the analyzes.
|
12 weeks
|
timed-up-and-go test
Time Frame: 12 weeks
|
The "Timed Up-And-Go" test, which evaluates the time it takes for the patient to get up from a chair, walk three meters, make a 180-degree turn, and return to the chair.
The patient should perform two attempts and the best performance will be considered for the analyzes.
|
12 weeks
|
Isometric strength
Time Frame: 12 weeks
|
handgrip test
|
12 weeks
|
Maximal strength test
Time Frame: 12 weeks
|
will be performed by the maximum repetition test, where the objective is to find a maximal repetition for lower limbs by leg press exercise 45º and for upper limbs by bench press exercise
|
12 weeks
|
The Paediatric Vasculitis Activity Score (PVAS)
Time Frame: 12 weeks
|
The final PVAS is a clinical index of 64 manifestations of active vasculitis, divided into five domains: general, cutaneous, cardiovascular, abdominal and renal.
|
12 weeks
|
National Institute of Health (NIH)
Time Frame: 12 weeks
|
The NIH criteria is an instrument that will evalueted the disease specific symptoms and his activity.
Active disease will arbitrarily defined as new onset or worsening of at least 2 of the following 4 features: (I) signs and symptoms of vascular ischemia or inflammation (e.g.
claudication, decreased or absent extremity pulses or blood pressure, bruits, or carotidynia); (2) elevated erythrocyte sedimentation rate; (3) angiographic abnormalities; and (4) systemic symptoms not attributable to another disease.
|
12 weeks
|
Indian Takayasu's Arteritis Activity Score 2010 (ITAS2010
Time Frame: 12 weeks
|
ITAS2010 contains 44 items with 33 features arising from the cardiovascular system.
Seven key items are weighted to score 2 and all others score 1 only.
|
12 weeks
|
Childhood Health Assessment Questionaire (CHAQ)
Time Frame: 12 weeks
|
The Childhood Health Assessment Questionnaire (CHAQ) is a disease specific health instrument that measures functional ability in daily living activities in children
|
12 weeks
|
Physical activity levels
Time Frame: 12 weeks
|
The level of physical activity of patients will be measured using the Actigraph GT3x® triaxial accelerometer (Actigraph®).
|
12 weeks
|
Fatigue severity scale FSS
Time Frame: 12 weeks
|
The Fatigue severity scale will be used to monitor the change in fatigue in response to the intervention.
For each item, you must tick from 1 totally disagree to 7 agree totally.
The total number of points may vary from 9 to 63, and it is established that values equal to or greater than 28 are indicative of the presence of fatigue
|
12 weeks
|
Quality of life
Time Frame: 12 weeks
|
as assessed by Short-Form-36
|
12 weeks
|
Hypotension after acute exercise session
Time Frame: 12 weeks
|
after maximal aerobic capacity, the blood pressure will be will be measured in the four limbs, both arms and legs, every fifteen minutes, for an hour.
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Bruno BG Gualano, Professor, University of Sao Paulo
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 5, 2018
Primary Completion (Anticipated)
December 30, 2019
Study Completion (Anticipated)
December 30, 2019
Study Registration Dates
First Submitted
March 5, 2018
First Submitted That Met QC Criteria
April 10, 2018
First Posted (Actual)
April 11, 2018
Study Record Updates
Last Update Posted (Actual)
April 11, 2018
Last Update Submitted That Met QC Criteria
April 10, 2018
Last Verified
April 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Takayasu&Exercise
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Takayasu's Arteritis
-
Beijing Institute of Heart, Lung and Blood Vessel...Peking University People's Hospital; Shanghai Zhongshan HospitalRecruiting
-
University of PennsylvaniaNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompletedTakayasu's ArteritisUnited States, Canada
-
Seoul National University HospitalUnknownTakayasu's ArteritisKorea, Republic of
-
National Institute of Arthritis and Musculoskeletal...The Cleveland Clinic; Rare Diseases Clinical Research Network; Office of Rare...CompletedGiant Cell Arteritis | Takayasu's ArteritisUnited States, Canada
-
The Cleveland ClinicGE HealthcareCompletedVasculitis | Giant Cell Arteritis | Arteritis | Takayasu's Arteritis | AortitisUnited States
-
National Institute of Arthritis and Musculoskeletal...RecruitingGiant Cell Arteritis | Polyarteritis Nodosa | Takayasu's Arteritis | ANCA-Associated Vasculitis | Relapsing PolychondritisUnited States
-
University of PennsylvaniaNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsRecruitingGiant Cell Arteritis | Microscopic Polyangiitis | Polyarteritis Nodosa | Takayasu's Arteritis | Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss) | Granulomatosis With Polyangiitis (Wegener's)United States, Canada, Turkey
-
Centre Hospitalier Universitaire, AmiensWithdrawnRestenosis | Lower Limb ArteritisFrance
-
Assistance Publique - Hôpitaux de ParisChugai PharmaceuticalCompleted
-
Instituto Nacional de Cardiologia Ignacio ChavezCompleted
Clinical Trials on Exercise
-
University of Kansas Medical CenterRecruiting
-
National Institute of Neurological Disorders and...TerminatedTraumatic Brain InjuryUnited States
-
University of Texas, El PasoRecruitingKnee Osteoarthritis | Knee Pain Chronic | Central Pain SyndromeUnited States
-
Toronto Rehabilitation InstituteCompletedAcute Myeloid LeukemiaCanada
-
Sahmyook UniversityRecruitingChronic Nonspecific Neck PainKorea, Republic of
-
University of AlbertaWomen and Children's Health Research Institute, CanadaRecruitingType 1 Diabetes | Post-menopauseCanada
-
Uskudar UniversityCompleted
-
Yuksek Ihtisas UniversityCompletedDementia | Frailty | Cognitive Function | Reaction Time | Aerobic Exercise | Balance ExerciseTurkey
-
National Taiwan Normal UniversityCompletedAging | Cognitive DeclineTaiwan
-
Wayne State UniversityUnknown